Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Cerebral Angiography | 39 | 2024 | 1272 | 6.880 |
Why?
|
Cerebral Hemorrhage | 40 | 2023 | 2660 | 4.540 |
Why?
|
Carotid Stenosis | 13 | 2024 | 862 | 1.850 |
Why?
|
Hematoma | 16 | 2020 | 768 | 1.830 |
Why?
|
Tomography, X-Ray Computed | 52 | 2025 | 20776 | 1.800 |
Why?
|
Cerebrovascular Disorders | 7 | 2024 | 1486 | 1.740 |
Why?
|
Magnetic Resonance Angiography | 12 | 2024 | 1434 | 1.690 |
Why?
|
Aneurysm, Ruptured | 4 | 2020 | 462 | 1.340 |
Why?
|
Intracranial Hemorrhages | 7 | 2023 | 811 | 1.240 |
Why?
|
Stroke | 26 | 2024 | 9756 | 1.050 |
Why?
|
Carotid Arteries | 6 | 2017 | 943 | 1.040 |
Why?
|
Intracranial Aneurysm | 5 | 2020 | 1293 | 1.030 |
Why?
|
Carotid Artery, Internal | 8 | 2022 | 445 | 0.970 |
Why?
|
Extravasation of Diagnostic and Therapeutic Materials | 3 | 2016 | 101 | 0.900 |
Why?
|
Tomography, Spiral Computed | 5 | 2014 | 274 | 0.890 |
Why?
|
Microscopic Polyangiitis | 1 | 2023 | 46 | 0.860 |
Why?
|
Churg-Strauss Syndrome | 1 | 2023 | 75 | 0.840 |
Why?
|
Glial Fibrillary Acidic Protein | 1 | 2025 | 564 | 0.820 |
Why?
|
Takotsubo Cardiomyopathy | 1 | 2024 | 125 | 0.800 |
Why?
|
Vasospasm, Intracranial | 2 | 2024 | 214 | 0.790 |
Why?
|
Ubiquitin Thiolesterase | 1 | 2025 | 465 | 0.760 |
Why?
|
Angiography, Digital Subtraction | 3 | 2019 | 332 | 0.730 |
Why?
|
Infarction, Middle Cerebral Artery | 3 | 2020 | 487 | 0.720 |
Why?
|
Vasculitis, Central Nervous System | 1 | 2019 | 45 | 0.660 |
Why?
|
Intracranial Thrombosis | 1 | 2020 | 108 | 0.630 |
Why?
|
Hospital Mortality | 9 | 2016 | 5369 | 0.630 |
Why?
|
Seaweed | 1 | 2018 | 18 | 0.620 |
Why?
|
Biota | 1 | 2018 | 23 | 0.610 |
Why?
|
Subarachnoid Hemorrhage | 3 | 2024 | 1039 | 0.600 |
Why?
|
Herpes Zoster Ophthalmicus | 1 | 2018 | 37 | 0.600 |
Why?
|
Sensitivity and Specificity | 23 | 2025 | 14752 | 0.590 |
Why?
|
Intracranial Arteriosclerosis | 1 | 2019 | 138 | 0.580 |
Why?
|
Contrast Media | 12 | 2020 | 5334 | 0.580 |
Why?
|
Thrombectomy | 1 | 2022 | 675 | 0.550 |
Why?
|
Headache | 2 | 2024 | 1264 | 0.540 |
Why?
|
Ultrasonography, Doppler, Duplex | 4 | 2013 | 198 | 0.530 |
Why?
|
Ultrasonography, Doppler, Transcranial | 3 | 2016 | 279 | 0.520 |
Why?
|
Thrombotic Microangiopathies | 1 | 2016 | 124 | 0.480 |
Why?
|
Fishes | 1 | 2018 | 606 | 0.480 |
Why?
|
Aged, 80 and over | 42 | 2024 | 59739 | 0.470 |
Why?
|
Radiographic Image Interpretation, Computer-Assisted | 5 | 2020 | 1232 | 0.470 |
Why?
|
Angiography | 4 | 2022 | 1598 | 0.460 |
Why?
|
Neck Injuries | 2 | 2010 | 162 | 0.450 |
Why?
|
Vasa Vasorum | 1 | 2013 | 25 | 0.450 |
Why?
|
Echoencephalography | 1 | 2014 | 134 | 0.440 |
Why?
|
Hematoma, Subdural, Intracranial | 2 | 2014 | 30 | 0.440 |
Why?
|
Carotid Artery Diseases | 4 | 2017 | 878 | 0.430 |
Why?
|
Cranial Fossa, Posterior | 1 | 2014 | 134 | 0.430 |
Why?
|
Magnetic Resonance Imaging | 23 | 2024 | 36854 | 0.430 |
Why?
|
Aged | 65 | 2024 | 171786 | 0.430 |
Why?
|
Diagnostic Imaging | 5 | 2023 | 3538 | 0.420 |
Why?
|
Middle Aged | 66 | 2024 | 223737 | 0.410 |
Why?
|
Antihypertensive Agents | 5 | 2021 | 2027 | 0.400 |
Why?
|
Ischemic Attack, Transient | 4 | 2024 | 877 | 0.400 |
Why?
|
Humans | 131 | 2025 | 768970 | 0.400 |
Why?
|
Nervous System Diseases | 4 | 2019 | 1665 | 0.400 |
Why?
|
Hematoma, Subdural | 1 | 2013 | 128 | 0.390 |
Why?
|
Predictive Value of Tests | 18 | 2025 | 15471 | 0.390 |
Why?
|
Perfusion Imaging | 2 | 2024 | 196 | 0.380 |
Why?
|
Brain | 13 | 2024 | 27453 | 0.380 |
Why?
|
Craniocerebral Trauma | 2 | 2010 | 495 | 0.370 |
Why?
|
Image Enhancement | 2 | 2017 | 2898 | 0.370 |
Why?
|
Retrospective Studies | 44 | 2024 | 81903 | 0.370 |
Why?
|
Endarterectomy, Carotid | 3 | 2024 | 557 | 0.360 |
Why?
|
Posthumous Conception | 1 | 2010 | 11 | 0.360 |
Why?
|
Diffusion Magnetic Resonance Imaging | 4 | 2023 | 2831 | 0.350 |
Why?
|
Male | 79 | 2024 | 365203 | 0.350 |
Why?
|
Third-Party Consent | 1 | 2010 | 66 | 0.350 |
Why?
|
Female | 76 | 2024 | 397515 | 0.340 |
Why?
|
Hypoxia, Brain | 1 | 2010 | 139 | 0.330 |
Why?
|
Central Nervous System Neoplasms | 3 | 2024 | 930 | 0.330 |
Why?
|
Cerebral Veins | 1 | 2011 | 159 | 0.330 |
Why?
|
Wounds, Nonpenetrating | 3 | 2010 | 807 | 0.330 |
Why?
|
Respiratory Paralysis | 1 | 2009 | 32 | 0.330 |
Why?
|
Cerebral Infarction | 2 | 2006 | 975 | 0.320 |
Why?
|
Image Processing, Computer-Assisted | 9 | 2017 | 9080 | 0.320 |
Why?
|
Head Injuries, Closed | 1 | 2010 | 133 | 0.320 |
Why?
|
Oocyte Retrieval | 1 | 2010 | 162 | 0.320 |
Why?
|
Sinus Thrombosis, Intracranial | 1 | 2010 | 110 | 0.320 |
Why?
|
Phlebography | 1 | 2010 | 326 | 0.320 |
Why?
|
Mediterranean Sea | 3 | 2018 | 13 | 0.310 |
Why?
|
Stents | 3 | 2024 | 3200 | 0.310 |
Why?
|
Skull Fractures | 1 | 2010 | 203 | 0.310 |
Why?
|
Radiographic Image Enhancement | 3 | 2014 | 877 | 0.300 |
Why?
|
Trauma Severity Indices | 1 | 2009 | 479 | 0.300 |
Why?
|
Algorithms | 7 | 2023 | 14201 | 0.290 |
Why?
|
Observer Variation | 8 | 2017 | 2623 | 0.280 |
Why?
|
Brain Diseases | 2 | 2014 | 1558 | 0.280 |
Why?
|
Acute Disease | 7 | 2024 | 7245 | 0.280 |
Why?
|
Middle Cerebral Artery | 3 | 2016 | 273 | 0.270 |
Why?
|
Collateral Circulation | 2 | 2024 | 291 | 0.270 |
Why?
|
Imaging, Three-Dimensional | 3 | 2020 | 4076 | 0.270 |
Why?
|
Vascular Diseases | 2 | 2019 | 1163 | 0.270 |
Why?
|
Fibrinolytic Agents | 4 | 2024 | 2080 | 0.250 |
Why?
|
ROC Curve | 8 | 2022 | 3629 | 0.250 |
Why?
|
Ultrasonography | 2 | 2019 | 6002 | 0.240 |
Why?
|
Tracheostomy | 1 | 2009 | 430 | 0.240 |
Why?
|
Diagnosis, Differential | 10 | 2024 | 13021 | 0.240 |
Why?
|
Cerebral Arterial Diseases | 2 | 2023 | 82 | 0.240 |
Why?
|
Risk Factors | 22 | 2024 | 74976 | 0.230 |
Why?
|
Reproducibility of Results | 14 | 2023 | 20245 | 0.230 |
Why?
|
Adult | 37 | 2024 | 223851 | 0.220 |
Why?
|
Nicardipine | 2 | 2021 | 60 | 0.220 |
Why?
|
Brain Ischemia | 4 | 2017 | 3008 | 0.210 |
Why?
|
Pneumocephalus | 1 | 2023 | 46 | 0.200 |
Why?
|
Arterial Occlusive Diseases | 3 | 2016 | 746 | 0.200 |
Why?
|
Models, Theoretical | 1 | 2014 | 3580 | 0.200 |
Why?
|
Spinal Cord Injuries | 1 | 2009 | 929 | 0.190 |
Why?
|
Antibodies, Antineutrophil Cytoplasmic | 1 | 2023 | 297 | 0.190 |
Why?
|
Arteries | 2 | 2023 | 1126 | 0.190 |
Why?
|
Adolescent | 16 | 2019 | 89244 | 0.180 |
Why?
|
Cerebrovascular Circulation | 3 | 2024 | 2734 | 0.180 |
Why?
|
Young Adult | 16 | 2024 | 60131 | 0.180 |
Why?
|
Thrombolytic Therapy | 3 | 2024 | 2055 | 0.180 |
Why?
|
Vision Disorders | 2 | 2021 | 1093 | 0.180 |
Why?
|
Ultrasonography, Doppler | 1 | 2002 | 463 | 0.170 |
Why?
|
Prognosis | 14 | 2018 | 30046 | 0.170 |
Why?
|
Hypertension | 1 | 2019 | 8617 | 0.170 |
Why?
|
Severity of Illness Index | 10 | 2016 | 15951 | 0.160 |
Why?
|
Basilar Artery | 2 | 2015 | 207 | 0.160 |
Why?
|
Spain | 2 | 2018 | 485 | 0.160 |
Why?
|
Echo-Planar Imaging | 2 | 2023 | 674 | 0.160 |
Why?
|
Disease Progression | 10 | 2020 | 13674 | 0.160 |
Why?
|
Marine Biology | 1 | 2018 | 17 | 0.160 |
Why?
|
Glasgow Coma Scale | 4 | 2017 | 579 | 0.160 |
Why?
|
Leukoaraiosis | 1 | 2020 | 115 | 0.160 |
Why?
|
Constriction, Pathologic | 1 | 2022 | 1104 | 0.150 |
Why?
|
Geologic Sediments | 2 | 2017 | 81 | 0.150 |
Why?
|
Glyburide | 1 | 2018 | 117 | 0.150 |
Why?
|
Bivalvia | 1 | 2017 | 55 | 0.150 |
Why?
|
Plaque, Atherosclerotic | 3 | 2019 | 1550 | 0.150 |
Why?
|
Perfusion | 2 | 2022 | 1402 | 0.150 |
Why?
|
Respiration, Artificial | 1 | 2009 | 2725 | 0.150 |
Why?
|
Syndrome | 1 | 2024 | 3274 | 0.150 |
Why?
|
Emergency Medical Services | 1 | 2009 | 1947 | 0.140 |
Why?
|
Multivariate Analysis | 9 | 2020 | 12095 | 0.140 |
Why?
|
Herpesvirus 3, Human | 1 | 2018 | 159 | 0.140 |
Why?
|
Ultrasonography, Doppler, Color | 2 | 2015 | 234 | 0.140 |
Why?
|
Databases as Topic | 1 | 2018 | 475 | 0.140 |
Why?
|
Early Termination of Clinical Trials | 1 | 2016 | 70 | 0.130 |
Why?
|
Hemorrhage | 1 | 2009 | 3466 | 0.130 |
Why?
|
Gerstmann Syndrome | 1 | 2016 | 4 | 0.130 |
Why?
|
Incidence | 6 | 2017 | 21547 | 0.130 |
Why?
|
Plasminogen Activators | 1 | 2016 | 199 | 0.130 |
Why?
|
Apolipoproteins E | 2 | 2012 | 1461 | 0.130 |
Why?
|
Child | 11 | 2019 | 80960 | 0.130 |
Why?
|
Metals, Heavy | 1 | 2017 | 149 | 0.130 |
Why?
|
Time Factors | 9 | 2024 | 40261 | 0.130 |
Why?
|
Cohort Studies | 13 | 2018 | 41808 | 0.130 |
Why?
|
Circle of Willis | 1 | 2015 | 77 | 0.130 |
Why?
|
Herpes Zoster | 1 | 2018 | 252 | 0.130 |
Why?
|
Anterior Cerebral Artery | 1 | 2015 | 50 | 0.130 |
Why?
|
Blood Pressure | 4 | 2021 | 8544 | 0.120 |
Why?
|
Causality | 2 | 2013 | 1256 | 0.120 |
Why?
|
Warfarin | 3 | 2014 | 1493 | 0.120 |
Why?
|
Lymphoma | 1 | 2024 | 1900 | 0.120 |
Why?
|
Blood-Brain Barrier | 1 | 2002 | 1036 | 0.120 |
Why?
|
Pons | 1 | 2016 | 242 | 0.120 |
Why?
|
Survival Rate | 6 | 2013 | 12873 | 0.120 |
Why?
|
Hypocalcemia | 1 | 2016 | 205 | 0.120 |
Why?
|
Water Movements | 1 | 2014 | 17 | 0.120 |
Why?
|
Single-Blind Method | 2 | 2015 | 1586 | 0.120 |
Why?
|
Teleradiology | 1 | 2014 | 52 | 0.120 |
Why?
|
Apolipoprotein E2 | 2 | 2012 | 134 | 0.110 |
Why?
|
Brain Edema | 1 | 2018 | 607 | 0.110 |
Why?
|
Blood Cells | 1 | 2016 | 309 | 0.110 |
Why?
|
Avitaminosis | 1 | 2014 | 35 | 0.110 |
Why?
|
Central Nervous System Infections | 1 | 2014 | 61 | 0.110 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 2021 | 1376 | 0.110 |
Why?
|
Research Design | 1 | 2009 | 6214 | 0.110 |
Why?
|
Incidental Findings | 1 | 2018 | 697 | 0.110 |
Why?
|
Climate | 1 | 2014 | 146 | 0.110 |
Why?
|
Water Pollutants, Chemical | 1 | 2017 | 359 | 0.110 |
Why?
|
Intracranial Arteriovenous Malformations | 1 | 2016 | 366 | 0.110 |
Why?
|
Ecosystem | 1 | 2017 | 494 | 0.110 |
Why?
|
Radiography | 4 | 2014 | 6991 | 0.110 |
Why?
|
Brain Concussion | 1 | 2025 | 1436 | 0.110 |
Why?
|
Prospective Studies | 11 | 2024 | 54962 | 0.110 |
Why?
|
Moyamoya Disease | 1 | 2016 | 274 | 0.110 |
Why?
|
Craniopharyngioma | 1 | 2015 | 279 | 0.100 |
Why?
|
Logistic Models | 7 | 2020 | 13318 | 0.100 |
Why?
|
Area Under Curve | 3 | 2014 | 1645 | 0.100 |
Why?
|
Matrix Metalloproteinase 2 | 1 | 2014 | 462 | 0.100 |
Why?
|
Conservation of Natural Resources | 1 | 2014 | 209 | 0.100 |
Why?
|
Neuroprotective Agents | 1 | 2018 | 958 | 0.100 |
Why?
|
Treatment Outcome | 14 | 2024 | 65480 | 0.100 |
Why?
|
Chi-Square Distribution | 3 | 2017 | 3438 | 0.100 |
Why?
|
Waldenstrom Macroglobulinemia | 1 | 2021 | 1077 | 0.100 |
Why?
|
Radiology, Interventional | 1 | 2016 | 483 | 0.090 |
Why?
|
Child, Preschool | 7 | 2019 | 42683 | 0.090 |
Why?
|
Penis | 1 | 2012 | 210 | 0.090 |
Why?
|
False Positive Reactions | 1 | 2014 | 963 | 0.090 |
Why?
|
Brazil | 1 | 2015 | 1250 | 0.090 |
Why?
|
Anticoagulants | 4 | 2022 | 4850 | 0.090 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2014 | 633 | 0.090 |
Why?
|
Public Health | 1 | 2024 | 2680 | 0.090 |
Why?
|
AIDS-Related Opportunistic Infections | 1 | 2014 | 664 | 0.090 |
Why?
|
Risk Assessment | 7 | 2024 | 24333 | 0.090 |
Why?
|
Odds Ratio | 4 | 2018 | 9684 | 0.090 |
Why?
|
Postoperative Hemorrhage | 1 | 2014 | 420 | 0.090 |
Why?
|
Patient Admission | 2 | 2012 | 1370 | 0.090 |
Why?
|
Ethics Committees, Clinical | 1 | 2010 | 56 | 0.090 |
Why?
|
Blood Loss, Surgical | 1 | 2014 | 643 | 0.090 |
Why?
|
Biopsy | 2 | 2019 | 6805 | 0.090 |
Why?
|
Follow-Up Studies | 9 | 2016 | 39394 | 0.080 |
Why?
|
Erectile Dysfunction | 1 | 2013 | 445 | 0.080 |
Why?
|
Washington | 1 | 2010 | 315 | 0.080 |
Why?
|
Infant | 6 | 2019 | 36556 | 0.080 |
Why?
|
Image Interpretation, Computer-Assisted | 2 | 2020 | 3411 | 0.080 |
Why?
|
Catheters, Indwelling | 1 | 2012 | 436 | 0.080 |
Why?
|
Neoplasm Proteins | 1 | 2021 | 3608 | 0.080 |
Why?
|
Brucella melitensis | 1 | 2008 | 7 | 0.080 |
Why?
|
Boston | 2 | 2013 | 9377 | 0.080 |
Why?
|
Jugular Veins | 1 | 2010 | 211 | 0.080 |
Why?
|
Brucellosis | 1 | 2008 | 21 | 0.080 |
Why?
|
Comparative Effectiveness Research | 1 | 2014 | 714 | 0.080 |
Why?
|
Carotid Artery, Common | 1 | 2009 | 175 | 0.080 |
Why?
|
Eye Diseases | 2 | 2021 | 658 | 0.080 |
Why?
|
Educational Measurement | 1 | 2016 | 1260 | 0.080 |
Why?
|
Delayed Diagnosis | 1 | 2012 | 468 | 0.080 |
Why?
|
Databases, Factual | 1 | 2024 | 8094 | 0.080 |
Why?
|
Behcet Syndrome | 1 | 2009 | 86 | 0.080 |
Why?
|
Hospitals, General | 1 | 2013 | 810 | 0.080 |
Why?
|
Infusions, Intra-Arterial | 1 | 2008 | 221 | 0.080 |
Why?
|
Environment | 1 | 2014 | 1122 | 0.080 |
Why?
|
Intracranial Hypertension | 1 | 2010 | 193 | 0.070 |
Why?
|
Anemia, Sickle Cell | 1 | 2016 | 1065 | 0.070 |
Why?
|
Vertebrobasilar Insufficiency | 1 | 2008 | 113 | 0.070 |
Why?
|
Epidural Abscess | 1 | 2008 | 94 | 0.070 |
Why?
|
Polychondritis, Relapsing | 1 | 2007 | 29 | 0.070 |
Why?
|
Tracheal Stenosis | 1 | 2009 | 228 | 0.070 |
Why?
|
Artifacts | 2 | 2023 | 1942 | 0.070 |
Why?
|
Pituitary Neoplasms | 1 | 2015 | 1326 | 0.070 |
Why?
|
Survival Analysis | 2 | 2016 | 10115 | 0.070 |
Why?
|
Mutation | 3 | 2024 | 30266 | 0.070 |
Why?
|
Vasculitis | 2 | 2009 | 525 | 0.070 |
Why?
|
Withholding Treatment | 1 | 2010 | 620 | 0.060 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2009 | 278 | 0.060 |
Why?
|
Proto-Oncogene Proteins B-raf | 1 | 2015 | 2059 | 0.060 |
Why?
|
Wounds and Injuries | 2 | 2012 | 2517 | 0.060 |
Why?
|
Ear Diseases | 1 | 2007 | 181 | 0.060 |
Why?
|
Vertebral Artery | 1 | 2006 | 185 | 0.060 |
Why?
|
Cryopreservation | 1 | 2010 | 734 | 0.060 |
Why?
|
Comorbidity | 3 | 2017 | 10592 | 0.060 |
Why?
|
Aortic Aneurysm, Abdominal | 1 | 2014 | 1252 | 0.060 |
Why?
|
Infant, Premature | 1 | 2014 | 2123 | 0.060 |
Why?
|
Molecular Targeted Therapy | 1 | 2015 | 2830 | 0.060 |
Why?
|
Gadolinium | 1 | 2009 | 965 | 0.060 |
Why?
|
Mammography | 1 | 2014 | 2434 | 0.050 |
Why?
|
Coronary Stenosis | 1 | 2009 | 802 | 0.050 |
Why?
|
Calcium | 1 | 2016 | 5792 | 0.050 |
Why?
|
Functional Laterality | 1 | 2010 | 2267 | 0.050 |
Why?
|
Trachea | 1 | 2009 | 1095 | 0.050 |
Why?
|
Cerebrospinal Fluid | 2 | 2021 | 545 | 0.050 |
Why?
|
Optic Nerve | 2 | 2021 | 571 | 0.050 |
Why?
|
Emergency Service, Hospital | 2 | 2014 | 7957 | 0.050 |
Why?
|
Penile Erection | 2 | 2013 | 101 | 0.050 |
Why?
|
Malaria, Falciparum | 1 | 2011 | 1077 | 0.050 |
Why?
|
Testosterone | 1 | 2013 | 2493 | 0.050 |
Why?
|
Curriculum | 1 | 2016 | 3782 | 0.050 |
Why?
|
Regression Analysis | 1 | 2012 | 6346 | 0.050 |
Why?
|
Genetic Association Studies | 1 | 2011 | 2748 | 0.050 |
Why?
|
Hypoventilation | 1 | 2001 | 44 | 0.050 |
Why?
|
Viscera | 1 | 2002 | 138 | 0.050 |
Why?
|
Pulmonary Artery | 1 | 2010 | 1945 | 0.050 |
Why?
|
Intubation, Intratracheal | 1 | 2009 | 1359 | 0.050 |
Why?
|
Myosin Heavy Chains | 1 | 2023 | 404 | 0.050 |
Why?
|
Plasmodium falciparum | 1 | 2011 | 1741 | 0.050 |
Why?
|
Environmental Monitoring | 2 | 2017 | 1469 | 0.050 |
Why?
|
Eye Pain | 1 | 2021 | 46 | 0.050 |
Why?
|
Evidence-Based Medicine | 1 | 2013 | 3709 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6901 | 0.050 |
Why?
|
Prevalence | 4 | 2013 | 15879 | 0.040 |
Why?
|
Occupational Diseases | 1 | 2008 | 1458 | 0.040 |
Why?
|
Heart Arrest | 1 | 2010 | 1515 | 0.040 |
Why?
|
Calcinosis | 1 | 2009 | 1479 | 0.040 |
Why?
|
Skin | 1 | 2014 | 4506 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2021 | 406 | 0.040 |
Why?
|
Diffusion | 1 | 2002 | 818 | 0.040 |
Why?
|
RNA, Messenger | 1 | 2014 | 12806 | 0.040 |
Why?
|
DNA, Neoplasm | 1 | 2024 | 1748 | 0.040 |
Why?
|
Reference Standards | 2 | 2015 | 1014 | 0.040 |
Why?
|
Personnel Staffing and Scheduling | 1 | 2002 | 497 | 0.040 |
Why?
|
Abdominal Injuries | 1 | 2002 | 362 | 0.040 |
Why?
|
Bioprosthesis | 1 | 2002 | 593 | 0.040 |
Why?
|
Whole Body Imaging | 1 | 2010 | 284 | 0.040 |
Why?
|
Uncertainty | 1 | 2023 | 769 | 0.040 |
Why?
|
Veins | 1 | 2002 | 769 | 0.040 |
Why?
|
Ecology | 1 | 2017 | 105 | 0.040 |
Why?
|
Cardiovascular Diseases | 2 | 2013 | 15661 | 0.040 |
Why?
|
Tuberculosis | 2 | 2008 | 2029 | 0.040 |
Why?
|
Neoplasm Recurrence, Local | 1 | 2015 | 9442 | 0.030 |
Why?
|
Trauma Centers | 1 | 2002 | 951 | 0.030 |
Why?
|
Acute Kidney Injury | 1 | 2009 | 1936 | 0.030 |
Why?
|
Rupture, Spontaneous | 1 | 2017 | 365 | 0.030 |
Why?
|
Pulmonary Embolism | 1 | 2010 | 2600 | 0.030 |
Why?
|
Optic Disk | 1 | 2021 | 422 | 0.030 |
Why?
|
Platelet Aggregation Inhibitors | 2 | 2022 | 2763 | 0.030 |
Why?
|
Endovascular Procedures | 2 | 2024 | 2218 | 0.030 |
Why?
|
Gene Expression Regulation | 1 | 2014 | 11932 | 0.030 |
Why?
|
Clinical Trials as Topic | 1 | 2012 | 8055 | 0.030 |
Why?
|
Intensive Care Units | 1 | 2009 | 3800 | 0.030 |
Why?
|
Endpoint Determination | 1 | 2018 | 594 | 0.030 |
Why?
|
Animals | 3 | 2018 | 169335 | 0.030 |
Why?
|
Central Nervous System | 1 | 2023 | 1346 | 0.030 |
Why?
|
Length of Stay | 1 | 2009 | 6526 | 0.030 |
Why?
|
Child Nutritional Physiological Phenomena | 1 | 1997 | 294 | 0.030 |
Why?
|
Brain Neoplasms | 1 | 2016 | 9213 | 0.030 |
Why?
|
Adenine | 1 | 2021 | 995 | 0.030 |
Why?
|
Hematologic Tests | 1 | 2016 | 239 | 0.030 |
Why?
|
Cerebral Cortex | 1 | 2011 | 5831 | 0.030 |
Why?
|
Speech Disorders | 1 | 2016 | 180 | 0.030 |
Why?
|
Iodine | 1 | 2017 | 286 | 0.030 |
Why?
|
Infant, Newborn | 2 | 2014 | 26428 | 0.030 |
Why?
|
Heart Valve Diseases | 1 | 2002 | 1030 | 0.030 |
Why?
|
Calibration | 1 | 2017 | 822 | 0.030 |
Why?
|
Antineoplastic Combined Chemotherapy Protocols | 1 | 2015 | 11886 | 0.030 |
Why?
|
Oximes | 1 | 2015 | 303 | 0.030 |
Why?
|
Ascorbic Acid Deficiency | 1 | 2014 | 26 | 0.030 |
Why?
|
Fractals | 1 | 2014 | 127 | 0.030 |
Why?
|
Valine | 1 | 2015 | 410 | 0.030 |
Why?
|
Heart Valve Prosthesis | 1 | 2002 | 1468 | 0.030 |
Why?
|
Neoplasms | 1 | 2023 | 22389 | 0.030 |
Why?
|
Patient Simulation | 1 | 2016 | 297 | 0.030 |
Why?
|
Vitamin A Deficiency | 1 | 2014 | 88 | 0.030 |
Why?
|
Genotype | 3 | 2012 | 13048 | 0.030 |
Why?
|
Pyrimidinones | 1 | 2015 | 386 | 0.030 |
Why?
|
Patient Care Planning | 1 | 2018 | 904 | 0.030 |
Why?
|
Aortic Valve | 1 | 2002 | 1969 | 0.030 |
Why?
|
Problem-Based Learning | 1 | 2016 | 360 | 0.020 |
Why?
|
Piperidines | 1 | 2021 | 1667 | 0.020 |
Why?
|
Pain | 2 | 2021 | 5100 | 0.020 |
Why?
|
Hemodynamics | 1 | 2002 | 4199 | 0.020 |
Why?
|
Coitus | 1 | 2012 | 133 | 0.020 |
Why?
|
Point-of-Care Systems | 2 | 2011 | 1240 | 0.020 |
Why?
|
Aorta, Abdominal | 1 | 2014 | 627 | 0.020 |
Why?
|
Craniotomy | 1 | 2015 | 747 | 0.020 |
Why?
|
HIV Infections | 1 | 2017 | 17591 | 0.020 |
Why?
|
Peripheral Vascular Diseases | 1 | 2013 | 489 | 0.020 |
Why?
|
Data Interpretation, Statistical | 2 | 2012 | 2714 | 0.020 |
Why?
|
Neoplasm, Residual | 1 | 2015 | 1019 | 0.020 |
Why?
|
Recurrence | 1 | 2023 | 8513 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2012 | 18068 | 0.020 |
Why?
|
Pyridones | 1 | 2015 | 819 | 0.020 |
Why?
|
Software | 2 | 2017 | 4479 | 0.020 |
Why?
|
Glutamic Acid | 1 | 2015 | 1191 | 0.020 |
Why?
|
Demography | 1 | 2014 | 1642 | 0.020 |
Why?
|
Echocardiography, Doppler, Color | 1 | 2011 | 353 | 0.020 |
Why?
|
Imidazoles | 1 | 2015 | 1169 | 0.020 |
Why?
|
Waist Circumference | 1 | 2013 | 935 | 0.020 |
Why?
|
Thromboembolism | 1 | 2016 | 1004 | 0.020 |
Why?
|
Brain Stem | 1 | 2014 | 862 | 0.020 |
Why?
|
Exanthema | 1 | 2014 | 503 | 0.020 |
Why?
|
Reperfusion | 1 | 2010 | 266 | 0.020 |
Why?
|
Genital Diseases, Male | 1 | 2009 | 84 | 0.020 |
Why?
|
Phantoms, Imaging | 1 | 2017 | 2533 | 0.020 |
Why?
|
Anti-Inflammatory Agents | 2 | 2009 | 1811 | 0.020 |
Why?
|
Mortality | 1 | 2020 | 2914 | 0.020 |
Why?
|
International Normalized Ratio | 1 | 2010 | 382 | 0.020 |
Why?
|
Muscle, Smooth, Vascular | 1 | 2014 | 1493 | 0.020 |
Why?
|
Case-Control Studies | 2 | 2020 | 22296 | 0.020 |
Why?
|
Erythema | 1 | 2009 | 261 | 0.020 |
Why?
|
Apolipoprotein E4 | 1 | 2012 | 712 | 0.020 |
Why?
|
Otitis Externa | 1 | 2007 | 17 | 0.020 |
Why?
|
Drug Administration Schedule | 1 | 2015 | 4862 | 0.020 |
Why?
|
Tissue Plasminogen Activator | 1 | 2013 | 1165 | 0.020 |
Why?
|
Disease-Free Survival | 1 | 2017 | 6856 | 0.020 |
Why?
|
Breast Neoplasms | 1 | 2014 | 21188 | 0.020 |
Why?
|
Neck Pain | 1 | 2008 | 191 | 0.020 |
Why?
|
Tuberculosis, Central Nervous System | 1 | 2006 | 17 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2017 | 6547 | 0.020 |
Why?
|
Cholesterol, HDL | 1 | 2013 | 1820 | 0.020 |
Why?
|
Bacteria | 1 | 2017 | 2216 | 0.020 |
Why?
|
Nose Diseases | 1 | 2007 | 79 | 0.020 |
Why?
|
Demyelinating Diseases | 1 | 2009 | 358 | 0.020 |
Why?
|
Ear | 1 | 2007 | 172 | 0.020 |
Why?
|
Tuberculosis, Meningeal | 1 | 2006 | 49 | 0.020 |
Why?
|
Uganda | 1 | 2011 | 1361 | 0.020 |
Why?
|
Triglycerides | 1 | 2013 | 2464 | 0.020 |
Why?
|
Vascular Surgical Procedures | 1 | 2014 | 1515 | 0.020 |
Why?
|
Heart Block | 1 | 2007 | 390 | 0.020 |
Why?
|
United States | 3 | 2024 | 73186 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2007 | 436 | 0.020 |
Why?
|
Spleen | 1 | 2011 | 2294 | 0.010 |
Why?
|
Hospitals, Urban | 1 | 2006 | 499 | 0.010 |
Why?
|
Fatal Outcome | 1 | 2009 | 1836 | 0.010 |
Why?
|
Statistics, Nonparametric | 1 | 2010 | 2862 | 0.010 |
Why?
|
Vitamin D Deficiency | 1 | 2014 | 1388 | 0.010 |
Why?
|
Creatinine | 1 | 2009 | 1917 | 0.010 |
Why?
|
Edema | 1 | 2007 | 766 | 0.010 |
Why?
|
Night Care | 1 | 2002 | 28 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2017 | 12562 | 0.010 |
Why?
|
Prednisone | 1 | 2007 | 1567 | 0.010 |
Why?
|
Cervical Vertebrae | 1 | 2008 | 982 | 0.010 |
Why?
|
Computer Simulation | 1 | 2016 | 6291 | 0.010 |
Why?
|
Endothelium, Vascular | 1 | 2014 | 4428 | 0.010 |
Why?
|
Celiac Artery | 1 | 2002 | 65 | 0.010 |
Why?
|
After-Hours Care | 1 | 2002 | 102 | 0.010 |
Why?
|
Dominance, Cerebral | 1 | 2003 | 624 | 0.010 |
Why?
|
Mesenteric Veins | 1 | 2002 | 87 | 0.010 |
Why?
|
Mesenteric Arteries | 1 | 2002 | 178 | 0.010 |
Why?
|
Registries | 1 | 2017 | 8384 | 0.010 |
Why?
|
Fever | 1 | 2008 | 1619 | 0.010 |
Why?
|
Communicable Diseases | 1 | 2009 | 873 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2014 | 11116 | 0.010 |
Why?
|
Alcohol Drinking | 1 | 2013 | 4045 | 0.010 |
Why?
|
Sex Factors | 1 | 2014 | 10633 | 0.010 |
Why?
|
Wounds, Penetrating | 1 | 2002 | 316 | 0.010 |
Why?
|
Hypercapnia | 1 | 2001 | 260 | 0.010 |
Why?
|
Regional Blood Flow | 1 | 2003 | 1500 | 0.010 |
Why?
|
Massachusetts | 1 | 2013 | 8894 | 0.010 |
Why?
|
Vascular Patency | 1 | 2003 | 917 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2015 | 5707 | 0.010 |
Why?
|
Kidney Diseases | 1 | 2010 | 2100 | 0.010 |
Why?
|
Injury Severity Score | 1 | 2002 | 1049 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2014 | 19023 | 0.010 |
Why?
|
California | 1 | 2002 | 1443 | 0.010 |
Why?
|
DNA | 1 | 2012 | 7214 | 0.010 |
Why?
|
Occupational Exposure | 1 | 2008 | 1807 | 0.010 |
Why?
|
Blood Flow Velocity | 1 | 2001 | 1376 | 0.010 |
Why?
|
Sinusitis | 1 | 2007 | 998 | 0.010 |
Why?
|
Heart | 1 | 2011 | 4447 | 0.010 |
Why?
|
Cuba | 1 | 1997 | 48 | 0.010 |
Why?
|
Vasodilation | 1 | 2001 | 967 | 0.010 |
Why?
|
Pilot Projects | 1 | 2011 | 8748 | 0.010 |
Why?
|
Smoking | 1 | 2014 | 9094 | 0.010 |
Why?
|
HIV-1 | 1 | 2014 | 6962 | 0.010 |
Why?
|
Nutrition Disorders | 1 | 1997 | 204 | 0.010 |
Why?
|
Immunosuppressive Agents | 1 | 2009 | 4207 | 0.010 |
Why?
|
Genetic Variation | 1 | 2011 | 6611 | 0.010 |
Why?
|
Obesity | 2 | 2013 | 13091 | 0.010 |
Why?
|
Reference Values | 1 | 2001 | 4940 | 0.010 |
Why?
|
Anthropometry | 1 | 1997 | 1345 | 0.010 |
Why?
|
Cross-Sectional Studies | 1 | 2013 | 26395 | 0.010 |
Why?
|
Nutrition Surveys | 1 | 1997 | 1738 | 0.010 |
Why?
|
Nutritional Status | 1 | 1997 | 1627 | 0.000 |
Why?
|
Socioeconomic Factors | 1 | 1997 | 7861 | 0.000 |
Why?
|